November 15-16. 2021. Lyon, France. Inotrem is pleased to participate to the fifth edition of the Immunotherapies & Innovations for Infectious Diseases Congress (I4ID2021). Fostering quality interactions between hundreds of pharmaceutical companies, research labs, service providers, technology developers, and clinicians, I4ID has become a central event contributing to the development of innovative strategies against infectious diseases. During this his two-day congress, Margarita Salcedo-Magguilli, Chief Development Officer at Inotrem, will participate to a panel discussion on “Leveraging clinical trials data ». She will present a lecture entitled “TREM-1 as therapeutic target for COVID-19 critically ill patients with respiratory support, evaluation of the TREM-1 modulator nangibotide”.

More information https://www.i4id.org/